CytoReason

CytoReason owns one of the largest human molecular databases in the world and is a platform that makes these data accessible and useful, capable of transforming data into actionable biological insights for clinical and preclinical drug development programs. The company's platform uses proprietary data and machine learning (ML) models to reconstruct cellular information from bulk tissue, train immune-specific engines, and integrate multi-omics data, thereby generating a mechanistic understanding of the immune system, enabling pharmaceutical companies to discover and develop the right treatments for the right patients at the right time.